Pharmacotherapy for anxiety disorders and comorbid alcohol dependency

dc.contributor.authorWilson D.
dc.contributor.authorIpser J.C.
dc.contributor.authorStein D.J.
dc.date.accessioned2011-05-15T16:01:27Z
dc.date.available2011-05-15T16:01:27Z
dc.date.issued2008
dc.description.abstract[No abstract available]
dc.description.versionReview
dc.identifier.citationCochrane Database of Systematic Reviews
dc.identifier.citation4
dc.identifier.issn1469493X
dc.identifier.other10.1002/14651858.CD007505
dc.identifier.urihttp://hdl.handle.net/10019.1/11985
dc.subjectbenzodiazepine
dc.subjectlorazepam
dc.subjectmirtazapine
dc.subjectnaltrexone
dc.subjectplacebo
dc.subjectpregabalin
dc.subjectalcohol consumption
dc.subjectalcoholism
dc.subjectanxiety disorder
dc.subjectcognitive therapy
dc.subjectcomorbidity
dc.subjectdetoxification
dc.subjectdisease severity
dc.subjectdrug effect
dc.subjectdrug tolerability
dc.subjecthuman
dc.subjectreview
dc.subjecttreatment response
dc.subjectunspecified side effect
dc.titlePharmacotherapy for anxiety disorders and comorbid alcohol dependency
dc.typeReview
Files